Distribution of Nitrogen-13 from Labeled Nitrate (13No3-) in Humans and Rats
Authors
Affiliations
The body distribution of gavaged or intravenously administered nitrate labeled with nitrogen-13 was studied in humans and rats with the following results: (i) the labeled compound is not quickly absorbed from the stomach; (ii) the concentration of the label increases inside the lower intestinal tract (cercum and large intestine) when ingested or intravenously injected; and (iii) humans and rats have the capacity to store a portion of the label in their bodies. These observation indicate that depletion of body stores, the passage of nitrate down the gut, or the secretion of nitrate into the intestinal lumen may be a better explanation of the urinary, ileal, and fecal concentrations of nitrate and nitrite recently measured in humans that a bacterial nitrification reaction in the intestines, as suggested by Tannenbbaum et al.
Quantitative aspects of nitric oxide production from nitrate and nitrite.
Ghasemi A EXCLI J. 2022; 21:470-486.
PMID: 35391922 PMC: 8983853. DOI: 10.17179/excli2022-4727.
Li S, Jin H, Sun G, Zhang C, Wang J, Xu H Front Pharmacol. 2021; 12:634115.
PMID: 34163351 PMC: 8215696. DOI: 10.3389/fphar.2021.634115.
Nitrate and Nitrite in Health and Disease.
Ma L, Hu L, Feng X, Wang S Aging Dis. 2018; 9(5):938-945.
PMID: 30271668 PMC: 6147587. DOI: 10.14336/AD.2017.1207.
Mailman D Br J Pharmacol. 1994; 112(1):304-10.
PMID: 8032655 PMC: 1910284. DOI: 10.1111/j.1476-5381.1994.tb13069.x.
Biotransformation of nitric oxide, nitrite and nitrate.
Yoshida K, Kasama K, Kitabatake M, Imai M Int Arch Occup Environ Health. 1983; 52(2):103-15.
PMID: 6629503 DOI: 10.1007/BF00405415.